DK1805129T3 - (Biphenyl-)carboxylsyrer og derivater deraf - Google Patents

(Biphenyl-)carboxylsyrer og derivater deraf

Info

Publication number
DK1805129T3
DK1805129T3 DK05799330T DK05799330T DK1805129T3 DK 1805129 T3 DK1805129 T3 DK 1805129T3 DK 05799330 T DK05799330 T DK 05799330T DK 05799330 T DK05799330 T DK 05799330T DK 1805129 T3 DK1805129 T3 DK 1805129T3
Authority
DK
Denmark
Prior art keywords
biphenyl
derivatives
carboxylic acids
carboxylic
acids
Prior art date
Application number
DK05799330T
Other languages
Danish (da)
English (en)
Inventor
Francis Wilson
Alison Reid
Valerie Reader
Richard John Harrison
Mihiro Sunose
Remedios Hernandez-Perni
Jeremy Major
Cyrille Boussard
Kathryn Smelt
Jess Taylor
Adeline Leformal
Andrew Cansfield
Svenja Burckhardt
Original Assignee
Cellzome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellzome Ltd filed Critical Cellzome Ltd
Application granted granted Critical
Publication of DK1805129T3 publication Critical patent/DK1805129T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK05799330T 2004-10-21 2005-10-21 (Biphenyl-)carboxylsyrer og derivater deraf DK1805129T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04025003 2004-10-21
EP04026125A EP1650183A1 (fr) 2004-10-21 2004-11-04 L'acides acétiques (de benzyloxy-biphenyle) et de leurs derives ainsi que leurs utilisation en thérapie
US64210005P 2005-01-10 2005-01-10
PCT/EP2005/011349 WO2006045554A1 (fr) 2004-10-21 2005-10-21 Acides carboxylique (biphenyle) et leurs derives

Publications (1)

Publication Number Publication Date
DK1805129T3 true DK1805129T3 (da) 2009-06-02

Family

ID=34927231

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05799330T DK1805129T3 (da) 2004-10-21 2005-10-21 (Biphenyl-)carboxylsyrer og derivater deraf

Country Status (29)

Country Link
US (1) US7825160B2 (fr)
EP (2) EP1650183A1 (fr)
JP (1) JP5054532B2 (fr)
KR (1) KR101326358B1 (fr)
CN (1) CN101084178B (fr)
AP (1) AP2007003978A0 (fr)
AT (1) ATE425952T1 (fr)
AU (1) AU2005298880B2 (fr)
BR (1) BRPI0517467A (fr)
CA (1) CA2584664C (fr)
DE (1) DE602005013417D1 (fr)
DK (1) DK1805129T3 (fr)
EA (1) EA012417B1 (fr)
ES (1) ES2324307T3 (fr)
GE (1) GEP20105082B (fr)
HR (1) HRP20090316T1 (fr)
IL (1) IL182712A (fr)
MA (1) MA29514B1 (fr)
MX (1) MX2007004763A (fr)
NI (1) NI200700107A (fr)
NO (1) NO20072153L (fr)
NZ (1) NZ554724A (fr)
PL (1) PL1805129T3 (fr)
PT (1) PT1805129E (fr)
RS (1) RS50818B (fr)
SI (1) SI1805129T1 (fr)
SM (1) SMP200700016B (fr)
TN (1) TNSN07148A1 (fr)
WO (1) WO2006045554A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781469B2 (en) 2005-05-27 2010-08-24 Shionogi & Co., Ltd. Arylacetate derivatives having isoxazole skeleton
CA2686589A1 (fr) 2007-05-07 2008-11-13 Schering Corporation Modulateurs de gamma secretase
EP2152695A2 (fr) 2007-06-01 2010-02-17 Schering Corporation Modulateurs de sécrétase gamma
PE20090319A1 (es) 2007-06-01 2009-03-27 Schering Corp Moduladores de gamma secretasa
EP2178857A1 (fr) * 2007-06-29 2010-04-28 Schering Corporation Modulateurs de la gamma-sécrétase
JP2010538068A (ja) 2007-09-06 2010-12-09 シェーリング コーポレイション ガンマセクレターゼモジュレーター
AU2008312771B2 (en) * 2007-10-17 2012-11-01 Janssen Pharmaceutica, N.V. Biphenyl carboxylic acids and derivatives thereof
CN101903334A (zh) * 2007-10-19 2010-12-01 詹森药业有限公司 Gsm中间体
BRPI0817425A2 (pt) * 2007-10-19 2015-06-16 Janssen Pharmaceutica Nv Moduladores de gama-secretase ligados à amida
BRPI0817433A2 (pt) 2007-10-19 2015-06-16 Janssen Pharmaceutica Nv Moduladores de gama-secretase piperidinila e piperazinila
EA018862B1 (ru) 2007-10-19 2013-11-29 Янссен Фармацевтика, Н.В. МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ
AU2008312355B2 (en) * 2007-10-19 2013-07-04 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
EP2217604A1 (fr) 2007-11-05 2010-08-18 Schering Corporation Modulateurs de gamma-secrétase
WO2009067493A2 (fr) * 2007-11-19 2009-05-28 Envivo Pharmaceuticals, Inc. Benzènes 1,3,5-trisubstitués pour le traitement de la maladie d'alzheimer et d'autres troubles
JP2011506335A (ja) 2007-12-06 2011-03-03 シェーリング コーポレイション γ−セクレターゼ調節剤
US8426595B2 (en) 2007-12-11 2013-04-23 Xianhai Huang Gamma secretase modulators
RU2527177C2 (ru) 2007-12-20 2014-08-27 Энвиво Фармасьютикалз, Инк. Четырехзамещенные бензолы
EP2133322A1 (fr) * 2008-06-11 2009-12-16 CHIESI FARMACEUTICI S.p.A. Procédé de préparation de dérivés d'acide 1-(2-halobiphényl-4-yl)-cyclopropanecardxylique
CA2742472A1 (fr) 2008-11-13 2010-05-20 Schering Corporation Modulateurs de gamma secretase
US8673900B2 (en) 2008-11-13 2014-03-18 Merck Sharp & Dohme Corp. Gamma secretase modulators
CA2747744A1 (fr) 2008-12-22 2010-07-01 Theodros Asberom Modulateurs de gamma secretase
EP2379566A2 (fr) 2008-12-22 2011-10-26 Schering Corporation Modulateurs de gamma secretase
WO2010147975A1 (fr) 2009-06-16 2010-12-23 Schering Corporation Modulateurs de gamma sécrétase
US20120232108A1 (en) 2009-06-16 2012-09-13 Xianhai Huang Gamma secretase modulators
WO2010147969A2 (fr) 2009-06-16 2010-12-23 Schering Corporation Modulateurs de gamma sécrétase
US20120129189A1 (en) * 2009-07-17 2012-05-24 Chulan Kwon Methods of Controlling Cell Proliferation
SI2462098T1 (sl) * 2009-08-04 2014-01-31 Chiesi Farmaceutici S.P.A. Postopek priprave derivatov 1-(2-halobifenil-4-il)-ciklopropankarboksilne kisline
US9096586B2 (en) 2012-04-20 2015-08-04 Gilead Sciences, Inc. Therapeutic compounds
CN104045552B (zh) * 2013-03-13 2019-06-11 江苏先声药业有限公司 作为神经保护剂的药用化合物
WO2016201168A1 (fr) 2015-06-10 2016-12-15 Forum Pharmceuticals Inc. Composés oxadiazine et leurs méthodes d'utilisation
JP2021534215A (ja) * 2018-08-24 2021-12-09 ゼニオプロ ゲーエムベーハー 病的症状の治療における使用のための芳香族分子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US6869975B2 (en) * 2001-09-14 2005-03-22 Tularik Inc. Linked biaryl compounds
JP2006517925A (ja) * 2003-01-14 2006-08-03 メルク　エンド　カムパニー　インコーポレーテッド Ａβ４２低下薬としてのジェミナル二置換ＮＳＡＩＤ誘導体
ITMI20030312A1 (it) * 2003-02-21 2004-08-22 Chiesi Farma Spa Derivati di acidi 2-fenil-2-alchil-acetici per il trattamento della malattia di alzheimer.
GB0416508D0 (en) * 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
EP1657232A1 (fr) * 2004-11-05 2006-05-17 Cellzome Ag utilisation d'acides 2-arylacetiques alphasubstitues pour prevenir la maladie d'alzheimer

Also Published As

Publication number Publication date
EP1805129B1 (fr) 2009-03-18
EA200700860A1 (ru) 2007-10-26
CA2584664C (fr) 2014-05-27
PL1805129T3 (pl) 2009-08-31
CN101084178A (zh) 2007-12-05
EP1805129A1 (fr) 2007-07-11
EP1650183A1 (fr) 2006-04-26
US20090118289A1 (en) 2009-05-07
MA29514B1 (fr) 2008-06-02
JP5054532B2 (ja) 2012-10-24
KR20070085276A (ko) 2007-08-27
AU2005298880B2 (en) 2009-05-28
IL182712A0 (en) 2007-07-24
SMP200700016B (it) 2007-05-23
RS50818B (sr) 2010-08-31
SI1805129T1 (sl) 2009-08-31
WO2006045554A1 (fr) 2006-05-04
DE602005013417D1 (de) 2009-04-30
KR101326358B1 (ko) 2013-11-11
NO20072153L (no) 2007-06-26
GEP20105082B (en) 2010-09-27
JP2008517028A (ja) 2008-05-22
TNSN07148A1 (en) 2008-11-21
BRPI0517467A (pt) 2008-10-07
ES2324307T3 (es) 2009-08-04
EA012417B1 (ru) 2009-10-30
NZ554724A (en) 2009-11-27
US7825160B2 (en) 2010-11-02
CN101084178B (zh) 2012-03-28
MX2007004763A (es) 2007-09-27
PT1805129E (pt) 2009-06-23
NI200700107A (es) 2008-02-05
AP2007003978A0 (en) 2007-06-30
SMAP200700016A (fr) 2007-05-23
IL182712A (en) 2011-09-27
HRP20090316T1 (hr) 2009-07-31
AU2005298880A1 (en) 2006-05-04
CA2584664A1 (fr) 2006-05-04
ATE425952T1 (de) 2009-04-15

Similar Documents

Publication Publication Date Title
IL182712A0 (en) (biphenyl) carboxylic acids and derivatives thereof
NO20054958D0 (no) Substitulerte aminokarboksylsyrer
NO20054957D0 (no) Subtituerte karboksylsyrer
NO20055129D0 (no) Fenylsubstituerte karboksylsyrer
DK1842399T4 (da) Belysningsapparat og fremgangsmåde
NO2017017I1 (no) umeklinidium og vilanterol
IL182103A0 (en) Benzimidazole acetic acids exhibiting
NO20034669L (no) Karboksylsyrederivat og salt derav
EP1959182A4 (fr) Raccord rapide et contrôleur
BR0308476B1 (pt) dispositivo anastomàtico
IL183288A0 (en) Biaryloxymethylarene carboxylic acids
IS8204A (is) Tæki og aðferð til að hluta niður
NO20054969D0 (no) 2-cyanopropansyreamid- og esterderivater og deres anvendelse
ATE517887T1 (de) Neue 2-pyridincarbonsäureamidderivate
NO20054709D0 (no) Sammenfoyningssystem og anvendelse av dette
FI20055568L (fi) Menetelmä karboksyylihappoesteriseoksien valmistamiseksi ja niiden käyttö
ZA200809856B (en) Substituted biphenyl carboxylic acids and derivatives thereof
DK1732892T3 (da) Tetrahydrocarbazoler og derivater
DE602004025494D1 (de) Flüssiges cyclohexantricarbonsäureanhydrid
NL1032239A1 (nl) Sequentieel veldweergave-inrichting en werkwijze daarvoor.
ATE397582T1 (de) Neue dicarbonsäurederivate
DK1695956T3 (da) Cyklisk carboxylsyre-forbindelse og anvendelse deraf.
ATE421515T1 (de) Carbonsäureamide
DK1885716T3 (da) Thiazolderivater og anvendelse deraf
DK1840121T3 (da) Glycinderivat og anvendelse heraf